Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UnitedHealth Taps Cancer Group’s Compendium For Off-Label Oncology Coverage

This article was originally published in The Pink Sheet Daily

Executive Summary

While CMS does not recognize the National Comprehensive Cancer Network now as a reference for off-label cancer drug uses, the network expects that to change.

You may also be interested in...



FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Observational Study Quality Checklist Gets Mixed Reviews In Validation Study

The validation study finds challenges in correlating expert opinion on what is a good observational study that can be used for decision making and what the GRACE Initiative checklist predicts is a good study. Validation study author Robert Dubois believes the checklist can be predictive of a good study when the context of how an observational study’s findings are to be used is clear.

Topics

UsernamePublicRestriction

Register

PS067220

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel